Applications Development Center, Analytical Applications Department, Shimadzu Corporation, 1, Nishinokyo-Kuwabaracho, Nakagyo-ku, Kyoto 604-8511, Japan.
Anal Chem. 2010 Aug 1;82(15):6384-94. doi: 10.1021/ac100310x.
Alpha-Crystallin, which forms a huge multimeric complex that is essential for maintaining eye lens transparency, is one of the major proteins in the lens. The protein, which exists as isoforms alphaA and alphaB, functions as a molecular chaperone to restore the original conformations of distorted constituent proteins in the lens. This function is important to maintain the transparency of the lens, because there is no protein turnover in the lens. Abnormal aggregation of constituent proteins in the lens has been reported in cataract patients, and deamidation of Asn as well as racemization and isomerization of Asp have been found in the alpha-Crystallin of these patients. While the establishment of a quick and facile analytical method is eagerly anticipated to investigate the relevance of the isomerization to pathological states such as cataracts, differentiating the isomerization states is still not performed routinely. Here, we report the differentiation and semiquantitative analysis of an isoaspartic acid (betaAsp) in human alpha-Crystallin using postsource decay on a MALDI-TOF mass spectrometer incorporating a curved field reflectron. Our reproducible results of analyzing synthetic and tryptic peptides containing betaAsp corroborated results obtained using a previously reported diagnostic ion, y(l-n+1) - 46, for the differentiation of betaAsp. The relative content of betaAsp in the peptide was successfully estimated from a unique ratio, y(l-n):y(l-n+1), corresponding to cleavages at the C- and N-termini, respectively, of the isomeric residues. The betaAsp content was consistent with measurements obtained independently by reversed phase HPLC analysis. Experiments in which neighboring amino acids adjacent to betaAsp/Asp were substituted revealed that the ratio between y(l-n) and y(l-n+1) reflected the isomerization status, while the diagnostic ion was observed only in the peptides that included an arginine residue at their C-terminus. Postsource decay experiments utilizing both the diagnostic ion and the characteristic fragment pattern could be applied to various kinds of peptides containing betaAsp.
α-晶状体蛋白形成一个巨大的多聚体复合物,对于维持眼睛晶状体的透明性至关重要,是晶状体中的主要蛋白质之一。该蛋白质以αA 和 αB 两种同工型存在,作为分子伴侣发挥作用,可恢复晶状体中变形的结构蛋白的原始构象。这种功能对于维持晶状体的透明度非常重要,因为晶状体中没有蛋白质周转。在白内障患者的晶状体中已经报道了组成蛋白的异常聚集,并且已经在这些患者的α-晶状体蛋白中发现了天冬酰胺的脱酰胺以及天冬氨酸的外消旋和异构化。虽然人们迫切期待建立一种快速简便的分析方法来研究异构化与白内障等病理状态的相关性,但异构化状态的区分仍未常规进行。在这里,我们报告了使用 MALDI-TOF 质谱仪中的后源衰变对人α-晶状体蛋白中的异天冬氨酸(βAsp)进行区分和半定量分析,该质谱仪包含弯曲场反射器。我们对含有βAsp 的合成肽和胰蛋白酶肽进行分析的可重复结果与先前报道的用于区分βAsp 的诊断离子 y(l-n+1) - 46 的结果一致。通过独特的比率 y(l-n):y(l-n+1) 可以成功地从肽中估计βAsp 的相对含量,该比率分别对应于异构残基的 C-和 N-末端的裂解。βAsp 的含量与通过反相 HPLC 分析独立获得的测量值一致。实验中,将βAsp/Asp 相邻的氨基酸取代,发现 y(l-n) 和 y(l-n+1) 之间的比率反映了异构化状态,而诊断离子仅在其 C-末端包含精氨酸残基的肽中观察到。可以将利用诊断离子和特征片段模式的后源衰变实验应用于各种含有βAsp 的肽。